The AHA and six other organizations today submitted comments to the Drug Enforcement Administration on its proposed rule regarding controlled substances quotas. “Although we support DEA’s efforts to combat diversion, we are concerned that the proposed rule is focused on diversion to the exclusion of another critical factor — drug shortages,” the AHA and other groups wrote. “To ensure that legitimate medical needs are met, it is imperative that drug shortages be considered as aggregate production quotas are set and adjusted.” The letter also was signed by the Ambulatory Surgical Center Association, American Society of Clinical Oncology, American Society of Health-System Pharmacists, American Society of Anesthesiologists, Federation of American Hospitals, and Institute for Safe Medication Practices. The AHA last week submitted its own letter to DEA urging the agency to explicitly consider drug shortages when setting and adjusting aggregate production quotas, citing concern that the agency's proposal to reduce 2020 production quotas for five opioid controlled substances would exacerbate shortages of injectable opioid medications.

Related News Articles

Headline
The AHA’s Next Generation Leaders Fellowship July 29 announced its 36 fellows for the class of 2026, who will each work with mentors to address a specific…
Headline
The American Society for Health Care Engineering July 28 announced the recipients of its annual member awards during the 2025 Health Care Facilities Innovation…
Headline
AHA Chair-elect Marc Boom, M.D., president and CEO of Houston Methodist, and AHA Immediate-past Chair Joanne Conroy, M.D., president and CEO of Dartmouth…
Headline
Fairview Health Services, a Minneapolis-based nonprofit health system of 10 hospitals and medical centers serving the greater Twin Cities metro area and north-…
Headline
The Rural Hospital Excellence in Innovation Award honors rural hospitals that are leading the way in innovative, sustainable and community-centered care. If…
Headline
AHA’s Circle of Life Award celebrates innovation in palliative and end-of-life care and seeks to provide best practices and models for the field. Programs and…